Sham VeNS device

DEVICE2 trials

Sponsors

Neurovalens Ltd.

Conditions

Depressive Disorder, MajorMajor Depressive Disorder \(MDDParkinson Disease

Unknown Phase

Electrical Vestibular Nerve Stimulation (VeNS) in the Management of Parkinson's Disease

CompletedNCT04450550

Neurovalens Ltd.Parkinson Disease

Start: 2021-07-26End: 2022-11-01Updated: 2023-04-27

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)

Not yet recruitingNCT06470035

Neurovalens Ltd.Depressive Disorder, Major, Major Depressive Disorder \(MDD

Start: 2025-04-30End: 2027-04-30Target: 170Updated: 2024-08-09

Related Papers

Effectiveness of electrical vestibular nerve stimulation on the range of motion in patients with Parkinson’s disease

Journal of Basic and Clinical Physiology and Pharmacology2022-10-09

Effectiveness of electrical vestibular nerve stimulation as adjunctive therapy to improve the cognitive functions in patients with Parkinson’s disease

Journal of Basic and Clinical Physiology and Pharmacology2022-09-141 citations

Assessment of the efficacy of electrical vestibular nerve stimulation as an adjunct therapy in the management of motor functions and quality of life in patients with Parkinson’s disease

Asian Journal of Medical Sciences2022-03-012 citations

Assessment of the efficacy of electrical vestibular nerve stimulation as an adjunct therapy in the management of motor functions and quality of life in patients with Parkinson’s disease

Asian Journal of Medical Sciences2022-03-01